Cargando…

Translational Research of Telecare for the Treatment of Hepatitis C

Objective. Chronic hepatitis C virus (HCV) infection is a serious health problem in Taiwan. The high dropout rate due to side effects limits the efficacy of treatment. The objective of this study is to investigate the effectiveness of telecare for the treatment of chronic hepatitis. Material and Met...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Wan-Lin, Chiu, Wen-Ta, Wu, Ming-Shun, Hsu, Mei-Huang, Tsai, Shin-Han
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4071777/
https://www.ncbi.nlm.nih.gov/pubmed/25013762
http://dx.doi.org/10.1155/2014/195097
_version_ 1782322854510985216
author Chen, Wan-Lin
Chiu, Wen-Ta
Wu, Ming-Shun
Hsu, Mei-Huang
Tsai, Shin-Han
author_facet Chen, Wan-Lin
Chiu, Wen-Ta
Wu, Ming-Shun
Hsu, Mei-Huang
Tsai, Shin-Han
author_sort Chen, Wan-Lin
collection PubMed
description Objective. Chronic hepatitis C virus (HCV) infection is a serious health problem in Taiwan. The high dropout rate due to side effects limits the efficacy of treatment. The objective of this study is to investigate the effectiveness of telecare for the treatment of chronic hepatitis. Material and Methods. Two hundred and ninety-eight patients randomly chose either of the two support programs. Group 1 was offered public health nurse consultation at outpatient clinic. Group 2 was offered telecare program with 24 hours of consultation services via a health communication center. All patients were treated with standard therapy and followed up for 72 weeks. Results. Normalization of serum biochemistry was noted in both Group 1 (150 patients) and Group 2 (148 patients). The most common types of side effect in both groups were influenza-like symptoms. Patient compliance was 88% (Group 1) and 94.6% (Group 2). Total dropout cases were 18 (12%) in Group 1 and 8 (5.4%) in Group 2. The program costs were 232,632 USD (Group 1) and 112,500 USD (Group 2). Conclusion. Telecare system with health care communication center model is significant in reducing dropout rate and is more effective with easy access.
format Online
Article
Text
id pubmed-4071777
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-40717772014-07-10 Translational Research of Telecare for the Treatment of Hepatitis C Chen, Wan-Lin Chiu, Wen-Ta Wu, Ming-Shun Hsu, Mei-Huang Tsai, Shin-Han Biomed Res Int Clinical Study Objective. Chronic hepatitis C virus (HCV) infection is a serious health problem in Taiwan. The high dropout rate due to side effects limits the efficacy of treatment. The objective of this study is to investigate the effectiveness of telecare for the treatment of chronic hepatitis. Material and Methods. Two hundred and ninety-eight patients randomly chose either of the two support programs. Group 1 was offered public health nurse consultation at outpatient clinic. Group 2 was offered telecare program with 24 hours of consultation services via a health communication center. All patients were treated with standard therapy and followed up for 72 weeks. Results. Normalization of serum biochemistry was noted in both Group 1 (150 patients) and Group 2 (148 patients). The most common types of side effect in both groups were influenza-like symptoms. Patient compliance was 88% (Group 1) and 94.6% (Group 2). Total dropout cases were 18 (12%) in Group 1 and 8 (5.4%) in Group 2. The program costs were 232,632 USD (Group 1) and 112,500 USD (Group 2). Conclusion. Telecare system with health care communication center model is significant in reducing dropout rate and is more effective with easy access. Hindawi Publishing Corporation 2014 2014-06-10 /pmc/articles/PMC4071777/ /pubmed/25013762 http://dx.doi.org/10.1155/2014/195097 Text en Copyright © 2014 Wan-Lin Chen et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Study
Chen, Wan-Lin
Chiu, Wen-Ta
Wu, Ming-Shun
Hsu, Mei-Huang
Tsai, Shin-Han
Translational Research of Telecare for the Treatment of Hepatitis C
title Translational Research of Telecare for the Treatment of Hepatitis C
title_full Translational Research of Telecare for the Treatment of Hepatitis C
title_fullStr Translational Research of Telecare for the Treatment of Hepatitis C
title_full_unstemmed Translational Research of Telecare for the Treatment of Hepatitis C
title_short Translational Research of Telecare for the Treatment of Hepatitis C
title_sort translational research of telecare for the treatment of hepatitis c
topic Clinical Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4071777/
https://www.ncbi.nlm.nih.gov/pubmed/25013762
http://dx.doi.org/10.1155/2014/195097
work_keys_str_mv AT chenwanlin translationalresearchoftelecareforthetreatmentofhepatitisc
AT chiuwenta translationalresearchoftelecareforthetreatmentofhepatitisc
AT wumingshun translationalresearchoftelecareforthetreatmentofhepatitisc
AT hsumeihuang translationalresearchoftelecareforthetreatmentofhepatitisc
AT tsaishinhan translationalresearchoftelecareforthetreatmentofhepatitisc